CIK 0001580149
- Non-accelerated filer
- Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 462510769
- Phone
- +1 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 33,952 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 23,202 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 51,906 shares (to pay taxes)
- 4 Open-market buy President & CEO bought 10,000 shares
- 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 75,680 shares at $1.69 ($127,899)
- 4 Grant or award Director acquired 42,254 shares (grant or award)
- 4 Grant or award Director acquired 42,254 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 51,830 shares (grant or award)
- 4 Open-market buy President & CEO bought 10,000 shares at $1.78 ($17,800)
- 4 Open-market sale Director sold 8,560 shares at $3.05 ($26,108)
- 4 Open-market sale Director sold 10,805 shares at $3.50 ($37,827)
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 147 filings